Suppr超能文献

当保守的基因组序列被RNA干扰靶向时,1型人类免疫缺陷病毒的逃逸受到限制。

Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference.

作者信息

von Eije Karin Jasmijn, ter Brake Olivier, Berkhout Ben

机构信息

Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.

出版信息

J Virol. 2008 Mar;82(6):2895-903. doi: 10.1128/JVI.02035-07. Epub 2007 Dec 12.

Abstract

RNA interference (RNAi) is a cellular mechanism in which small interfering RNAs (siRNAs) mediate sequence-specific gene silencing by cleaving the targeted mRNA. RNAi can be used as an antiviral approach to silence the human immunodeficiency virus type 1 (HIV-1) through stable expression of short-hairpin RNAs (shRNAs). We previously reported efficient HIV-1 inhibition by an shRNA against the nonessential nef gene but also described viral escape by mutation or deletion of the nef target sequence. The objective of this study was to obtain insight in the viral escape routes when essential and highly conserved sequences are targeted in the Gag, protease, integrase, and Tat-Rev regions of HIV-1. Target sequences were analyzed of more than 500 escape viruses that were selected in T cells expressing individual shRNAs. Viruses acquired single point mutations, occasionally secondary mutations, but-in contrast to what is observed with nef-no deletions were detected. Mutations occurred predominantly at target positions 6, 8, 9, 14, and 15, whereas none were selected at positions 1, 2, 5, 18, and 19. We also analyzed the type of mismatch in the siRNA-target RNA duplex, and G-U base pairs were frequently selected. These results provide insight into the sequence requirements for optimal RNAi inhibition. This knowledge on RNAi escape may guide the design and selection of shRNAs for the development of an effective RNAi therapy for HIV-1 infections.

摘要

RNA干扰(RNAi)是一种细胞机制,其中小干扰RNA(siRNA)通过切割靶向mRNA介导序列特异性基因沉默。RNAi可作为一种抗病毒方法,通过短发夹RNA(shRNA)的稳定表达来沉默1型人类免疫缺陷病毒(HIV-1)。我们之前报道了一种针对非必需nef基因的shRNA对HIV-1的有效抑制作用,但也描述了通过nef靶序列的突变或缺失导致的病毒逃逸。本研究的目的是深入了解当HIV-1的Gag、蛋白酶、整合酶和Tat-Rev区域中的必需且高度保守序列被靶向时的病毒逃逸途径。对在表达单个shRNA的T细胞中选择的500多种逃逸病毒的靶序列进行了分析。病毒获得了单点突变,偶尔还有二级突变,但与nef基因情况不同的是,未检测到缺失。突变主要发生在靶位点6、8、9、14和15,而在位点1、2、5、18和19未选择任何突变。我们还分析了siRNA-靶RNA双链体中的错配类型,发现G-U碱基对经常被选择。这些结果为最佳RNAi抑制的序列要求提供了见解。关于RNAi逃逸的这一知识可能会指导shRNA的设计和选择,以开发针对HIV-1感染的有效RNAi疗法。

相似文献

3
Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition.
J Virol. 2004 Mar;78(5):2601-5. doi: 10.1128/jvi.78.5.2601-2605.2004.
4
RNA interference as a tool for exploring HIV-1 robustness.
J Mol Biol. 2011 Oct 14;413(1):84-96. doi: 10.1016/j.jmb.2011.08.035. Epub 2011 Aug 22.
5
Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
Mol Ther. 2006 Dec;14(6):883-92. doi: 10.1016/j.ymthe.2006.07.007. Epub 2006 Sep 7.
6
Trans-inhibition of HIV-1 by a long hairpin RNA expressed within the viral genome.
Retrovirology. 2007 Mar 1;4:15. doi: 10.1186/1742-4690-4-15.
7
Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs.
Retrovirology. 2010 Jun 8;7:52. doi: 10.1186/1742-4690-7-52.
8
Human immunodeficiency virus type 1 escape from RNA interference.
J Virol. 2003 Nov;77(21):11531-5. doi: 10.1128/jvi.77.21.11531-11535.2003.
9
Design of extended short hairpin RNAs for HIV-1 inhibition.
Nucleic Acids Res. 2007;35(17):5683-93. doi: 10.1093/nar/gkm596. Epub 2007 Aug 21.
10
HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome.
Nucleic Acids Res. 2005 Feb 1;33(2):796-804. doi: 10.1093/nar/gki220. Print 2005.

引用本文的文献

2
Evaluation of the effect of RNA secondary structure on Cas13d-mediated target RNA cleavage.
Mol Ther Nucleic Acids. 2024 Jul 20;35(3):102278. doi: 10.1016/j.omtn.2024.102278. eCollection 2024 Sep 10.
4
CRISPR-Cas12b enables a highly efficient attack on HIV proviral DNA in T cell cultures.
Biomed Pharmacother. 2023 Sep;165:115046. doi: 10.1016/j.biopha.2023.115046. Epub 2023 Jun 28.
5
A combinatorial CRISPR-Cas12a attack on HIV DNA.
Mol Ther Methods Clin Dev. 2022 Feb 26;25:43-51. doi: 10.1016/j.omtm.2022.02.010. eCollection 2022 Jun 9.
6
Potential Use of CRISPR/Cas13 Machinery in Understanding Virus-Host Interaction.
Front Microbiol. 2021 Nov 26;12:743580. doi: 10.3389/fmicb.2021.743580. eCollection 2021.
7
CRISPR-Cas13a Inhibits HIV-1 Infection.
Mol Ther Nucleic Acids. 2020 Sep 4;21:147-155. doi: 10.1016/j.omtn.2020.05.030. Epub 2020 Jun 1.
8
Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA.
Nucleic Acids Res. 2020 Jun 4;48(10):5527-5539. doi: 10.1093/nar/gkaa226.
9
Programmable Inhibition and Detection of RNA Viruses Using Cas13.
Mol Cell. 2019 Dec 5;76(5):826-837.e11. doi: 10.1016/j.molcel.2019.09.013. Epub 2019 Oct 10.
10
Elimination of infectious HIV DNA by CRISPR-Cas9.
Curr Opin Virol. 2019 Oct;38:81-88. doi: 10.1016/j.coviro.2019.07.001. Epub 2019 Aug 23.

本文引用的文献

2
Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition.
Mol Ther. 2008 Mar;16(3):557-64. doi: 10.1038/sj.mt.6300382. Epub 2008 Jan 15.
3
RNA interference against viruses: strike and counterstrike.
Nat Biotechnol. 2007 Dec;25(12):1435-43. doi: 10.1038/nbt1369.
4
Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
J Gene Med. 2007 Sep;9(9):743-50. doi: 10.1002/jgm.1078.
5
Combinatorial RNAi: a winning strategy for the race against evolving targets?
Mol Ther. 2007 May;15(5):878-88. doi: 10.1038/sj.mt.6300116. Epub 2007 Feb 20.
6
Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA.
Mol Ther. 2007 Mar;15(3):534-41. doi: 10.1038/sj.mt.6300077. Epub 2007 Jan 9.
7
RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Chin J Dig Dis. 2006;7(4):230-6. doi: 10.1111/j.1443-9573.2006.00268.x.
8
Stable inhibition of hepatitis B virus expression and replication in HepG2.2.15 cells by RNA interference based on retrovirus delivery.
J Biotechnol. 2007 Jan 30;128(1):32-40. doi: 10.1016/j.jbiotec.2006.09.007. Epub 2006 Sep 23.
9
Inhibition of hepatitis B virus expression and replication by RNA interference in HepG2.2.15.
World J Gastroenterol. 2006 Oct 7;12(37):6046-9. doi: 10.3748/wjg.v12.i37.6046.
10
Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
Mol Ther. 2006 Dec;14(6):883-92. doi: 10.1016/j.ymthe.2006.07.007. Epub 2006 Sep 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验